# Celecoxib

## Celebrex 200mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OCEL2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Indications        | 骨關節炎、類風濕性關節炎(B023177100) Relief of the signs & symptoms of osteoarthritis & RA. Management of acute pain & treatment of primary dysmenorrhea. To reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis (FAP)， as an adjunct to usual care. Ankylosing spondylitis.                                                                                                                                                                                                                                                                                    |
| Dosing             | Osteoarthritis: 200mg QD， or 100mg BID Rheumatoid arthritis: 100-200mg BID Ankylosing Spondylitis (AS):200mg/day in single (once a day) or divided (twice a day) dose. If it doesn't work after six weeks， try 400 mg/day. If there is no effect after another 6 weeks， there will be no therapeutic response， and other treatments should be considered. Relieve acute pain and treat primary dysmenorrhea: initial dose: 400mg， then 200 mg twice a day when needed.                                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Hypersensitivity to sulfonamides. Patients in whom aspirin or other NSAIDs induce symptoms of asthma， urticaria or allergic-type reactions.                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Abdominal pain， diarrhea， dyspepsia， flatulence， peripheral edema， dizziness， pharyngitis， rhinitis， sinusitis， upper respiratory tract infection， rash. Cardiovascular: Hypertension (arthritis， 2.4% ; familial adenomatous polyposis， 12.5% ) Gastrointestinal: Diarrhea (arthritis， 5.6%; familial adenomatous polyposis， 10.5%; juvenile rheumatoid arthritis， 4% to 5% )， Nausea (arthritis， 3.5%; familial adenomatous polyposis， 6.8%; juvenile rheumatoid arthritis， 4% to 7% ) Neurologic: Headache (arthritis， 15.8%; juvenile rheumatoid arthritis， 10% to 13% ) |
| Pregnancy          | Human data suggest risk in 1st and 3 rd trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

